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Background
Vitamin D has a role in bone metabolism, immunity and
possibly in the prevention of some cancers. There have
been varying reports of vitamin D deficiency in the HIV
population, as well as the possibility of deficiency being
caused by the HIV virus or HAART. Vitamin D deficiency
may also have an affect on the progression of HIV.
Methods
25 (OH) Vitamin D levels were taken between 8 am and
10 am on all the HIV-positive patients admitted over a 2-
month period (May & June) to Chelsea & Westminster
Hospital.
Summary of results
74 patients (17 women, 57 men) had their 25(OH)VitD
levels measured. Vitamin D deficiency is defined as <15
nmol/L, insufficiency as 15–50 nmol/L and normal >50
nmol/L. Sixteen (21.6%) patients were deficient, 33
(44.6%) insufficient and 25 (33.7%) were normal. Vita-
min D deficient patients, mean CD4 cell count 237,
median 179.5; Vitamin D insufficient patients, mean CD4
cell count 368, median 289; and patients with normal
Vitamin D levels had a mean CD4 cell count of 348,
median 340. Of the Vitamin D deficient patients, two
(12.5%) were not on HAART, 13 (81.2%) were on NRTI's,
eight (50%) were on NNRTI's, seven (43.7%) were on
PI's, and one (6.2%) was on raltegravir. Of the insufficient
patients, 12 (36.3%) were not on HAART, 19 (57.5%)
were on NRTI's, seven (21.2%) on NNRTI's, 13(39.3%)
on PI's, and two (6%) on raltegravir. The normal Vitamin
D group had 10 (40%) patients not on HAART, 14 (56%)
on NRTI's, 6 (24%) were on NNRTI'S, nine (36%) were
on PI's, and none were on raltegravir.
Conclusion
A significant number, 49 (66.2%), of our patients had
either vitamin D deficiency or insufficiency. There also
appears to be lower CD4 counts in the Vitamin D defi-
cient group of patients. Whether specific antiretrovirals
contribute to Vitamin D deficiency can not be confirmed
from these figures, however, further investigation into the
relationship between HIV, HAART and Vitamin D needs
to be undertaken.
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